- cafead Aug 14, 2024 at 11:12: AM
via Kezar plans to focus all efforts on zetomipzomib, which is being evaluated in two Phase II trials for lupus and autoimmune hepatitis.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
Kezar stalls solid tumor trial to focus on autoimmune disease candidate
- Thread starter cafead
- Start date
<
Similar threads